Major Step Forward for Taysha's TSHA-102 Gene Therapy in Rett Syndrome
The FDA has granted Breakthrough Therapy designation to TSHA-102 for Rett Syndrome, acknowledging its potential to redefine treatment.
/ 1680 items
#XY↓
GoodRx and Kroger Partner for Instant Drug Savings
GoodRx and Kroger launched RxSmartSaver at 2,200 pharmacies. Scan a code for instant discounts on brand drugs like Ozempic and Lantus.
Boosting the Fight Against Childhood Cancer with AI
Shares of Tempus AI rose following the executive order promoting the use of AI to develop solutions for pediatric cancer.
Fortress Biotech Stock Plummets After FDA Rejection
FDA rejected Fortress Biotech's Menkes drug, CUTX-101, due to factory issues, but the drug's safety and efficacy data were fine.
Halozyme is Set to Acquire Elektrofi in a Deal Worth up to $900M, Expanding its Lineup of Drug Delivery Products
Halozyme is buying Elektrofi ($900M) for Hypercon tech. This innovation concentrates powerful biologic drugs for small, easy shots. This means patients can use auto-injectors at home, boosting convenience and treatment access.
European Drugmakers Surge: Pfizer's US Pricing Deal Offers a Tariff Blueprint
Pfizer avoided US tariffs by offering big drug discounts (TrumpRx). This deal is a blueprint. European drug stocks (AstraZeneca, Roche) surged hoping for similar agreements to protect their crucial sales from Trump's 100% import tax threat.